Charge modified lactoferrin and carrageenin combination medicine and preparation method thereof

A technology of lactoferrin and charge modification, which is applied in the direction of drug combination, pharmaceutical formula, peptide/protein composition, etc., can solve the problems of high price, unquantitative research, and unclear curative effect, and achieve high negative conversion rate and good curative effect , Ease of use

Active Publication Date: 2015-11-11
NANJING LAKESEN BIOPHARM TECH CO LTD
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the limitation of detection methods, the detection of HPV adopts methods such as histopathology, colposcopy or PCR, and has not been applied to HC2 (HPV DNA second-generation hybrid capture detection technology), and quantitative research has not been performed on it.
[0004] At present, great enthusiasm has been poured into the research and development of new drugs and biological agents that have preventive and control effects on a variet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Charge modified lactoferrin and carrageenin combination medicine and preparation method thereof
  • Charge modified lactoferrin and carrageenin combination medicine and preparation method thereof
  • Charge modified lactoferrin and carrageenin combination medicine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1: Preparation of charge-modified lactoferrin

[0033] Put 1.65 (0.8-16.5) parts by weight of 3-hydroxy-phthalic anhydride (HP) in a 10mL small beaker, add an appropriate amount of dimethyl sulfoxide (DMSO), and stir at 200-500rpm in a magnetic stirrer, At the same time, DMSO was added dropwise to about 10 (5-100) parts by weight to prepare a saturated HP solution; under stirring at 200-500 rpm, 2 g of lactoferrin was dissolved in 100 mL of 0.1 M sodium phosphate buffer solution to prepare a 20 mg / mL solution. Protein solution; then take saturated HP solution and 20mg / mL protein solution and mix at a ratio of 1:100, stir for 15-30min to mix evenly, and adjust the pH to 10 with phosphoric acid or sodium phosphate, let it stand at 25°C for 1h, and use pH7.4 dialyzed with PBS, and sterilized by 0.45 μm membrane filtration to obtain charge-modified lactoferrin, specifically as figure 1 shown.

Embodiment 2

[0034] Embodiment 2: combination medicine

[0035] The combined medicine consists of 0.01 parts by weight of LK protein (charge-modified lactoferrin), 1.5 parts by weight of carrageenan and auxiliary materials, a total of 100 parts by weight. The auxiliary materials include 5 parts by weight of carbomer, 50 parts by weight of glycerin, 0.1 parts by weight of ethylparaben, the combined medicine is a kind of gel, suppository and dressing.

Embodiment 3

[0036] Embodiment 3: the preparation method of combination medicine

[0037] S1: Weigh each raw material according to the proportion, stir 0.5g carbomer in water at 80°C until fully swollen, add 0.15g carrageenan, stir until completely dissolved, and filter and sterilize through a 0.22μm membrane while hot to obtain 1 No. solution;

[0038] S2: Dissolve 0.01g of ethylparaben in water, then add 5g of glycerol, filter and sterilize through a 0.22μm membrane to obtain No. 2 solution;

[0039] S3: Add No. 2 solution to No. 1 solution under agitation and mix evenly, add 0.8 g of triethanolamine, adjust the pH to 5.5, and obtain No. 3 solution;

[0040] S4: Dissolve 0.001g of LK protein in an appropriate amount of water with low-speed stirring at room temperature, and filter and sterilize through a 0.22 μm membrane to obtain solution No. 4;

[0041] S5: under stirring at a certain temperature, add No. 4 solution into No. 3 solution and mix evenly, and adjust the pH to 5.5 with steri...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a charge modified lactoferrin and carrageenin combination medicine which comprises 0.01 part by weight of lactoferrin, 1.5 parts by weight of carrageenin, 5 parts by weight of carbomer, 50 parts by weight of glycerol and 0.1 part by weight of ethylparaben. The combination medicine is one of a gel, a suppository and a dressing. The combination medicine disclosed by the invention can be used for preventing and treating female human papilloma virus infection as well as preventing and treating female gynecological gram-negative bacterium infection.

Description

technical field [0001] The invention relates to the field of preparing anticancer drugs, in particular to a charge-modified lactoferrin-carrageenan combination drug and a preparation method thereof. Background technique [0002] Cervical cancer ranks fourth in the incidence of total cancer in my country, and ranks second in the incidence and mortality of female malignant tumors. Studies have found that HPV can be detected in about 99.7% of cervical cancer patients, among which high-risk HPV is closely related to cervical cancer . Every year, there are more than 500,000 new cases of cervical cancer worldwide, and more than 200,000 women die of cervical cancer. There are nearly 100,000 new cases of cervical cancer in China every year, accounting for nearly 20% of the total number of new cases in the world. Cervical cancer is the first cancer completely caused by HPV infection confirmed by the World Health Organization (WHO). HPV belongs to a group of DNA viruses in subgroup ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/40A61P31/20A61P31/04A61P15/00A61P35/00A61K31/731
Inventor 蒲晓辉徐天宏李建业董亚琴韦勇
Owner NANJING LAKESEN BIOPHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap